ARTIMPLANT AB INTERIM REPORT January 1 - March 31, 2006

• Net revenue amounted SEK 1.1 million (1.1) • Net profit of SEK -10.4 million (-9.1) • Earnings per share of SEK -0.17 (SEK -0.23) • Artelon® implant for rotator cuff reinforcement received clearance for marketing in the US and was launched by Biomet at AAOS in Chicago • Increased number of clinics using Artelon® products increased the underlying product sales run rate in the US and in Scandinavia • Artelon® DRU Spacer received CE-mark • Artelon® TMC Spacer cleared for marketing in Canada Events after the period • Tord Lendau resigns as CEO for private reasons